JPMorgan Chase & Co. has acquired a 5.9% stake in Korsana Biosciences, signaling strategic interest in the pharmaceutical sector.
| Name | Korsana Biosciences, Inc. |
|---|---|
| CIK | 0001755237 |
| Tickers | KRSA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 831895370 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | MA MA |
| Phone | (781) 516-2325 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
JPMorgan Chase & Co. has acquired a 5.9% stake in Korsana Biosciences, signaling strategic interest in the pharmaceutical sector.
Korsana Biosciences, Inc. has filed a registration statement to issue over 13 million shares, supporting its employee stock incentive plans.
Korsana Biosciences, Inc. reveals its Q3 financial results, emphasizing its commitment to innovation in the pharmaceutical industry.
Korsana Biosciences, Inc. announces its financial results for Q3 2026, reflecting its performance in the pharmaceutical preparations industry.
Korsana Biosciences has filed a Form 144, indicating a proposed sale of securities, potentially impacting its financial strategy and the pharmaceutical sector.
401 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011416 | 001-38787 | 261580407 | 33 | 5128 | |||
| 2026-11-20 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-011406 | 001-38787 | 261579888 | 33 | 4879 | |||
| 2026-11-19 | 8-K | 8-K | 5.07 | 0001193125-26-468661 | 001-38787 | 261575312 | 34 | 168090 | 1 | 1 |
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-128696 | 005-90979 | 261563690 | 34 | 11788 | |||
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-464095 | 005-90979 | 261563518 | 34 | 131315 | |||
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001274173-26-000284 | 005-90979 | 261558586 | 34 | 13079 | |||
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902219-26-000330 | 005-90979 | 261557735 | 34 | 17460 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005049 | 005-90979 | 261555104 | 34 | 15478 | |||
| 2026-11-10 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000019617-26-000402 | 005-90979 | 261538482 | 34 | 6905 | |||
| 2026-11-09 | S-8 | S-8 | 0001193125-26-453743 | 333-299932 | 261536650 | 33 | 303404 | 1 | 1 | |
| 2026-11-05 | 10-Q | 10-Q | 0001193125-26-448636 | 001-38787 | 261524892 | 34 | 9796509 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-448535 | 001-38787 | 261524707 | 34 | 324333 | 1 | 1 |
| 2026-10-22 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-010364 | 001-38787 | 261478933 | 33 | 6585 | |||
| 2026-10-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-047257 | 005-90979 | 261463401 | 34 | 9114 | |||
| 2026-10-15 | DEF 14A | DEF 14A | 0001193125-26-422893 | 001-38787 | 261463232 | 34 | 1061607 | |||
| 2026-10-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002345 | 005-90979 | 261446098 | 34 | 11732 | |||
| 2026-10-05 | PRE 14A | PRE 14A | 0001193125-26-414133 | 001-38787 | 261440535 | 34 | 1060994 | |||
| 2026-09-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009776 | 001-38787 | 261401511 | 33 | 6523 | |||
| 2026-09-22 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009757 | 001-38787 | 261397464 | 33 | 5756 | |||
| 2026-09-18 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000950142-26-002568 | 005-90979 | 261392012 | 34 | 84002 | |||
| 2026-09-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009679 | 001-38787 | 261391536 | 33 | 4991 | |||
| 2026-09-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001903360-26-000015 | 005-90979 | 261382403 | 34 | 6879 | |||
| 2026-09-15 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001738048-26-000069 | 005-90979 | 261381520 | 34 | 49508 | |||
| 2026-09-11 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-389417 | 005-90979 | 261375275 | 34 | 161167 | |||
| 2026-09-11 | 8-K | 8-K | 1.01,2.01,2.02,3.02,3.03,5.01,5.02,5.03,5.05,5.06,7.01,9.01 | 0001193125-26-389318 | 001-38787 | 261374665 | 34 | 2479729 | 1 | 1 |
| 2026-09-10 | 4 | 4 | 0001193125-26-388146 | 5654 | ||||||
| 2026-09-10 | 4 | 4 | 0001193125-26-388144 | 6510 | ||||||
| 2026-09-10 | 4 | 4 | 0001193125-26-388142 | 13665 | ||||||
| 2026-09-10 | 4 | 4 | 0001193125-26-388136 | 6456 | ||||||
| 2026-09-10 | 3 | 3 | 0001193125-26-388127 | 21743 | ||||||
| 2026-09-10 | 3 | 3 | 0001193125-26-388126 | 17792 | ||||||
| 2026-09-10 | 3 | 3 | 0001193125-26-388123 | 16314 | ||||||
| 2026-09-10 | 3 | 3 | 0001193125-26-388120 | 16467 | ||||||
| 2026-09-10 | 3 | 3 | 0001193125-26-388115 | 13226 | ||||||
| 2026-09-10 | 3 | 3 | 0001193125-26-388112 | 32754 | ||||||
| 2026-09-10 | 3 | 3 | 0001193125-26-388110 | 23213 | ||||||
| 2026-09-10 | 3 | 3 | 0001193125-26-388094 | 17540 | ||||||
| 2026-08-27 | 8-K | 8-K | 5.07,8.01,9.01 | 0001193125-26-369426 | 001-38787 | 261324861 | 34 | 202109 | 1 | 1 |
| 2026-08-25 | 425 | 425 | 0001193125-26-365166 | 001-38787 | 261315998 | 34 | 29967 | |||
| 2026-08-25 | 8-K | 8-K | 8.01 | 0001193125-26-365150 | 001-38787 | 261315962 | 34 | 153516 | 1 | 1 |
| 2026-08-18 | 4 | 4 | 0001193125-26-355721 | 7617 | ||||||
| 2026-08-18 | 4 | 4 | 0001193125-26-355707 | 9085 | ||||||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097419 | 005-90979 | 261284490 | 34 | 15136 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003423 | 005-90979 | 261275804 | 34 | 14815 | |||
| 2026-08-12 | 425 | 425 | 0001193125-26-346989 | 001-38787 | 261268076 | 34 | 292852 | |||
| 2026-08-10 | 425 | 425 | 0001193125-26-342584 | 001-38787 | 261259241 | 34 | 269212 | |||
| 2026-08-06 | 425 | 425 | 0001193125-26-338459 | 001-38787 | 261250496 | 34 | 363849 | |||
| 2026-08-04 | 10-Q | 10-Q | 0001193125-26-332842 | 001-38787 | 261238916 | 34 | 5936092 | 1 | 1 | |
| 2026-08-03 | 425 | 425 | 0001193125-26-330785 | 001-38787 | 261234229 | 34 | 43042 | |||
| 2026-07-24 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002441 | 333-295175 | 261202719 | 33 | 1716 | ||
| 2026-07-24 | 424B3 | 424B3 | 0001193125-26-316138 | 333-295175 | 261201775 | 33 | 13067837 | |||
| 2026-07-22 | S-4/A | S-4/A | 0001193125-26-312558 | 333-295175 | 261194476 | 33 | 25916317 | 1 | 1 | |
| 2026-07-20 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-309245 | 005-90979 | 261187904 | 34 | 8300 | |||
| 2026-07-20 | 4 | 4 | 0001193125-26-309048 | 10287 | ||||||
| 2026-07-10 | 425 | 425 | 0001193125-26-301054 | 001-38787 | 261169526 | 34 | 9223042 | |||
| 2026-07-10 | S-4/A | S-4/A | 0001193125-26-299933 | 333-295175 | 261166643 | 33 | 26494824 | 1 | 1 | |
| 2026-06-09 | S-4/A | S-4/A | 0001193125-26-263731 | 333-295175 | 261076146 | 33 | 23789640 | 1 | 1 | |
| 2026-05-12 | 10-Q | 10-Q | 0001193125-26-219478 | 001-38787 | 26968749 | 34 | 5609608 | 1 | 1 | |
| 2026-05-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-001385 | 005-90979 | 26951553 | 34 | 11279 | |||
| 2026-04-30 | 10-K/A | 10-K/A | 0001193125-26-194204 | 001-38787 | 26920299 | 34 | 889802 | 1 | 1 | |
| 2026-04-20 | S-4 | S-4 | 0001193125-26-162177 | 333-295175 | 26873192 | 33 | 22376214 | 1 | 1 | |
| 2026-04-01 | 425 | 425 | 0001193125-26-137985 | 001-38787 | 26828623 | 34 | 9763351 | |||
| 2026-04-01 | 8-K | 8-K | 1.01,5.01,5.02,7.01,9.01 | 0001193125-26-137909 | 001-38787 | 26828288 | 34 | 10299752 | 1 | 1 |
| 2026-03-30 | 10-K | 10-K | 0001193125-26-132193 | 001-38787 | 26814700 | 34 | 9113388 | 1 | 1 | |
| 2026-02-17 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-053035 | 001-38787 | 26636382 | 34 | 184300 | 1 | 1 |
| 2026-01-06 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-26-003509 | 001-38787 | 26509492 | 34 | 8657270 | 1 | 1 |
| 2025-12-01 | 8-K | 8-K | 8.01 | 0001193125-25-304067 | 001-38787 | 251540645 | 34 | 137458 | 1 | 1 |
| 2025-11-12 | 10-Q | 10-Q | 0001193125-25-277749 | 001-38787 | 251473449 | 34 | 6661975 | 1 | 1 | |
| 2025-11-12 | 10-K/A | 10-K/A | 0001193125-25-277621 | 001-38787 | 251472926 | 34 | 8865662 | 1 | 1 | |
| 2025-10-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-25-018450 | 005-90979 | 251400823 | 34 | 17519 | |||
| 2025-09-23 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-25-213332 | 001-38787 | 251333796 | 34 | 5632862 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001641172-25-024017 | 005-90979 | 251218779 | 34 | 7523 | |||
| 2025-08-11 | 4 | 4 | 0000950170-25-106532 | 5614 | ||||||
| 2025-08-05 | 10-Q | 10-Q | 0000950170-25-103123 | 001-38787 | 251185465 | 34 | 5970262 | 1 | 1 | |
| 2025-06-18 | 8-K | 8-K | 5.07,9.01 | 0001193125-25-142765 | 001-38787 | 251057490 | 34 | 160605 | 1 | 1 |
| 2025-05-15 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001628 | 333-287006 | 25956817 | 33 | 1715 | ||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001641172-25-010930 | 005-90979 | 25953345 | 34 | 7068 | |||
| 2025-05-13 | CORRESP | filename1.htm | 0001193125-25-118816 | 6934 | ||||||
| 2025-05-12 | UPLOAD | filename1.pdf | 0000000000-25-005035 | 333-287006 | 40042 | |||||
| 2025-05-07 | 8-K | 8-K | 1.01,9.01 | 0001193125-25-115089 | 001-38787 | 25922845 | 34 | 417354 | 1 | 1 |
| 2025-05-07 | 424B5 | 424B5 | 0001193125-25-115085 | 333-284690 | 25922810 | 33 | 358881 | |||
| 2025-05-06 | S-3 | S-3 | 0001193125-25-113869 | 333-287006 | 25918094 | 33 | 341709 | |||
| 2025-05-06 | 10-Q | 10-Q | 0000950170-25-064493 | 001-38787 | 25917454 | 34 | 5395155 | 1 | 1 | |
| 2025-04-29 | DEFA14A | DEFA 14A | 0001140361-25-016374 | 001-38787 | 25889134 | 34 | 1382054 | |||
| 2025-04-29 | DEF 14A | DEF 14A | 0001140361-25-016370 | 001-38787 | 25889090 | 34 | 4657756 | 1 | 1 | |
| 2025-03-28 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000950170-25-047124 | 005-90979 | 25788492 | 34 | 9772 | |||
| 2025-03-27 | 4 | 4 | 0000950170-25-046280 | 7431 | ||||||
| 2025-03-27 | 4 | 4 | 0000950170-25-046099 | 4760 | ||||||
| 2025-03-25 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-25-062612 | 001-38787 | 25768879 | 34 | 517990 | 1 | 1 |
| 2025-03-04 | 10-K | 10-K | 0000950170-25-032037 | 001-38787 | 25704604 | 34 | 9943461 | 1 | 1 | |
| 2025-02-12 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000427 | 333-284690 | 25616931 | 33 | 1722 | ||
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-018782 | 005-90979 | 25614523 | 34 | 14840 | |||
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-018622 | 005-90979 | 25613852 | 34 | 6174 | |||
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-000869 | 005-90979 | 25612546 | 34 | 11275 | |||
| 2025-02-10 | CORRESP | filename1.htm | 0001193125-25-023605 | 6802 | ||||||
| 2025-02-07 | UPLOAD | filename1.pdf | 0000000000-25-001353 | 333-284690 | 40118 | |||||
| 2025-02-04 | S-3 | S-3 | 0001193125-25-020077 | 333-284690 | 25588967 | 33 | 406771 | |||
| 2024-12-17 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-24-280125 | 001-38787 | 241553713 | 34 | 225601 | 1 | 1 |
| 2024-12-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-24-006852 | 005-90979 | 241532267 | 34 | 9071 | |||
| 2024-11-25 | 4 | xslF345X05/ownership.xml | 0000902664-24-006775 | 7893 | ||||||
| 2024-11-14 | 10-Q | 10-Q | 0000950170-24-127116 | 001-38787 | 241463109 | 34 | 7052598 | 1 | 1 | |
| 2024-08-07 | 4 | 4 | 0000950170-24-092733 | 5578 | ||||||
| 2024-08-07 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-195410 | 001-38787 | 241181414 | 34 | 177907 | 1 | 1 |
| 2024-08-07 | 10-Q | 10-Q | 0000950170-24-092257 | 001-38787 | 241181335 | 34 | 6391238 | 1 | 1 | |
| 2024-07-12 | SC 13G/A | SC 13G/A | 0001193125-24-178653 | 005-90979 | 241115421 | 34 | 166138 | |||
| 2024-06-14 | 8-K | 8-K | 5.07,9.01 | 0001193125-24-161591 | 001-38787 | 241044706 | 34 | 163602 | 1 | 1 |
| 2024-05-07 | 10-Q | 10-Q | 0000950170-24-054602 | 001-38787 | 24922490 | 34 | 5459549 | 1 | 1 | |
| 2024-04-29 | DEFA14A | DEFA14A | 0001140361-24-022986 | 001-38787 | 24891181 | 34 | 958282 | |||
| 2024-04-29 | DEF 14A | DEF 14A | 0001140361-24-022981 | 001-38787 | 24891088 | 34 | 1881887 | |||
| 2024-04-18 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-100763 | 001-38787 | 24854339 | 34 | 148583 | 1 | 1 |
| 2024-03-11 | 3 | 3 | 0000950170-24-029219 | 3569 | ||||||
| 2024-03-05 | 10-K | 10-K | 0000950170-24-025935 | 001-38787 | 24720587 | 34 | 10040572 | 1 | 1 | |
| 2024-02-14 | SC 13G/A | formsc13ga.htm | 0001493152-24-006650 | 005-90979 | 24637805 | 34 | 75812 | |||
| 2024-02-09 | SC 13G/A | SC 13G/A | 0001193125-24-030268 | 005-90979 | 24616027 | 34 | 164323 | |||
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-001049 | 005-90979 | 24611484 | 34 | 8027 | |||
| 2024-01-26 | 4 | 4 | 0000950170-24-007920 | 7522 | ||||||
| 2024-01-26 | 4 | 4 | 0000950170-24-007917 | 4894 | ||||||
| 2024-01-22 | SC 13G/A | CYCLERION THERAPEUTICS, INC. | 0000902664-24-000479 | 005-90979 | 24548663 | 34 | 60889 | |||
| 2023-12-28 | UPLOAD | filename1.pdf | 0000000000-23-014145 | 39703 | ||||||
| 2023-12-12 | CORRESP | filename1.htm | 0001193125-23-293378 | 85760 | ||||||
| 2023-12-11 | 3 | 3 | 0000950170-23-069443 | 3902 | ||||||
| 2023-12-07 | 3 | 3 | 0000950170-23-068795 | 4106 | ||||||
| 2023-12-07 | 3/A | 3/A | 0000950170-23-068792 | 4475 | ||||||
| 2023-12-05 | SC 13D/A | SC 13D/A | 0001104659-23-123609 | 005-90979 | 231466470 | 34 | 116822 | |||
| 2023-12-04 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-23-288498 | 001-38787 | 231464230 | 34 | 170106 | 1 | 1 |
| 2023-12-04 | 3 | 3 | 0000950170-23-067744 | 4032 | ||||||
| 2023-12-04 | 4 | 4 | 0000950170-23-067740 | 9330 | ||||||
| 2023-12-04 | 4 | 4 | 0000950170-23-067738 | 9301 | ||||||
| 2023-12-04 | 4 | 4 | 0000950170-23-067736 | 6546 | ||||||
| 2023-12-04 | 4 | 4 | 0000950170-23-067734 | 4734 | ||||||
| 2023-12-01 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-23-286790 | 001-38787 | 231457559 | 34 | 182283 | 1 | 1 |
| 2023-11-28 | UPLOAD | filename1.pdf | 0000000000-23-012909 | 47178 | ||||||
| 2023-11-24 | 8-K | 8-K | 5.02 | 0001193125-23-282705 | 001-38787 | 231436193 | 34 | 147142 | 1 | 1 |
| 2023-11-13 | 10-Q | 10-Q | 0000950170-23-063023 | 001-38787 | 231399314 | 34 | 8589101 | 1 | 1 | |
| 2023-10-23 | 8-K | 8-K | 5.02,9.01 | 0001140361-23-049190 | 001-38787 | 231340451 | 34 | 246406 | 1 | 1 |
| 2023-09-05 | SC 13G | formsc13g.htm | 0001493152-23-031649 | 005-90979 | 231235714 | 34 | 74658 | |||
| 2023-08-11 | 4 | FORM 4 SUBMISSION | 0000899243-23-018047 | 10837 | ||||||
| 2023-07-31 | S-8 | S-8 | 0001140361-23-036839 | 333-273530 | 231124568 | 33 | 101390 | |||
| 2023-07-28 | 10-Q | 10-Q | 0000950170-23-035558 | 001-38787 | 231123758 | 34 | 7122712 | 1 | 1 | |
| 2023-07-19 | 8-K | 8-K | 5.07,9.01 | 0001140361-23-035245 | 001-38787 | 231097623 | 34 | 187340 | 1 | 1 |
| 2023-07-12 | 8-K | 8-K | 8.01 | 0000950170-23-032664 | 001-38787 | 231084349 | 34 | 443584 | 1 | 1 |
| 2023-06-27 | 8-K | 8-K | 5.02 | 0000950170-23-030168 | 001-38787 | 231048131 | 34 | 191872 | 1 | 1 |
| 2023-06-20 | DEFM14A | DEFM14A | 0001140361-23-030510 | 001-38787 | 231025993 | 34 | 4222172 | |||
| 2023-06-09 | PREM14A | PREM14A | 0001140361-23-029172 | 001-38787 | 231006395 | 34 | 4267990 | |||
| 2023-06-01 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-025693 | 001-38787 | 23984704 | 34 | 230015 | 1 | 1 |
| 2023-05-25 | D | xslFormDX01/primary_doc.xml | 06b | 0001140361-23-026623 | 021-482661 | 23960506 | 33 | 9754 | ||
| 2023-05-25 | 8-K | 8-K | 3.02,5.03,9.01 | 0001140361-23-026621 | 001-38787 | 23960422 | 34 | 1476715 | 1 | 1 |
| 2023-05-23 | SC 13D/A | SC 13D/A | 0001104659-23-063613 | 005-90979 | 23948887 | 34 | 35788 | |||
| 2023-05-22 | 4 | xslF345X04/form4.xml | 0001140361-23-026101 | 10415 | ||||||
| 2023-05-15 | 8-K | 8-K | 3.03,5.03,5.07,7.01,8.01,9.01 | 0001140361-23-024768 | 001-38787 | 23924005 | 34 | 486478 | 1 | 1 |
| 2023-05-12 | SC 13D/A | SC 13D/A | 0001104659-23-059462 | 005-90979 | 23913397 | 34 | 44776 | |||
| 2023-05-12 | 10-Q | 10-Q | 0000950170-23-021448 | 001-38787 | 23912748 | 34 | 6034122 | 1 | 1 | |
| 2023-05-12 | DEFA14A | DEFA14A | 0001140361-23-024220 | 001-38787 | 23912738 | 34 | 680147 | |||
| 2023-05-12 | 8-K | 8-K | 1.01,2.02,3.02,7.01,8.01,9.01 | 0001140361-23-024218 | 001-38787 | 23912734 | 34 | 1061104 | 1 | 1 |
| 2023-04-03 | DEFA14A | DEFA14A | 0001140361-23-015811 | 001-38787 | 23793263 | 34 | 5203944 | |||
| 2023-04-03 | DEF 14A | DEF 14A | 0001140361-23-015808 | 001-38787 | 23793195 | 34 | 2727936 | |||
| 2023-04-03 | 8-K | 8-K | 7.01,9.01 | 0000950170-23-011500 | 001-38787 | 23791051 | 34 | 250372 | 1 | 1 |
| 2023-04-03 | SC 13D/A | SC 13D/A | 0001104659-23-040535 | 005-90979 | 23790616 | 34 | 242084 | |||
| 2023-03-22 | PRE 14A | PRE 14A | 0001140361-23-013099 | 001-38787 | 23753596 | 34 | 2840425 | |||
| 2023-03-22 | 10-K | 10-K | 0000950170-23-009223 | 001-38787 | 23753549 | 34 | 10372253 | 1 | 1 | |
| 2023-03-22 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-009221 | 001-38787 | 23753526 | 34 | 245032 | 1 | 1 |
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001464 | 005-90979 | 23601759 | 34 | 8088 | |||
| 2023-01-13 | SC 13G | CYCLERION THERAPEUTICS, INC. | 0000902664-23-000260 | 005-90979 | 23529116 | 34 | 77283 | |||
| 2022-11-29 | 8-K | 8-K | 3.01 | 0000950170-22-025791 | 001-38787 | 221432753 | 34 | 190086 | 1 | 1 |
| 2022-11-22 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-025613 | 001-38787 | 221410872 | 34 | 236651 | 1 | 1 |
| 2022-11-21 | SC 13D/A | SC 13D/A | 0001104659-22-120818 | 005-90979 | 221406547 | 34 | 31986 | |||
| 2022-11-03 | 10-Q | 10-Q | 0000950170-22-021966 | 001-38787 | 221358932 | 34 | 6948052 | 1 | 1 | |
| 2022-10-21 | SC 13D | sc13d13606002_10212022.htm | 0000921895-22-002849 | 005-90979 | 221324374 | 34 | 148399 | |||
| 2022-10-06 | 8-K | 8-K | 2.05,7.01,9.01 | 0000950170-22-019330 | 001-38787 | 221297125 | 34 | 263460 | 1 | 1 |
| 2022-09-30 | 8-K | 8-K | 5.02 | 0000950170-22-019124 | 001-38787 | 221284939 | 34 | 185905 | 1 | 1 |
| 2022-08-10 | S-8 | S-8 | 0001140361-22-029095 | 333-266739 | 221152408 | 33 | 120501 | |||
| 2022-08-09 | 10-Q | 10-Q | 0000950170-22-016032 | 001-38787 | 221148187 | 34 | 6603657 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-016016 | 001-38787 | 221148067 | 34 | 261699 | 1 | 1 |
| 2022-07-28 | 8-K | 8-K | 7.01,9.01 | 0000950170-22-013289 | 001-38787 | 221112996 | 34 | 3078515 | 1 | 1 |
| 2022-07-27 | 4/A | FORM 4/A | 0001140361-22-027144 | 5188 | ||||||
| 2022-07-26 | 4 | FORM 4 | 0001140361-22-026995 | 4889 | ||||||
| 2022-07-26 | 3 | FORM 3 | 0001140361-22-026990 | 10745 | ||||||
| 2022-07-26 | 8-K | 8-K | 5.02,7.01,9.01 | 0001140361-22-026908 | 001-38787 | 221104872 | 34 | 188399 | 1 | 1 |
| 2022-06-16 | 4 | FORM 4 | 0001140361-22-023335 | 4967 | ||||||
| 2022-06-16 | 4 | FORM 4 | 0001140361-22-023334 | 4904 | ||||||
| 2022-06-16 | 4 | FORM 4 | 0001140361-22-023333 | 4899 | ||||||
| 2022-06-16 | 4 | FORM 4 | 0001140361-22-023332 | 4900 | ||||||
| 2022-06-16 | 4 | FORM 4 | 0001140361-22-023331 | 4942 | ||||||
| 2022-06-16 | 4 | FORM 4 | 0001140361-22-023330 | 4886 | ||||||
| 2022-06-16 | 4 | FORM 4 | 0001140361-22-023329 | 4849 | ||||||
| 2022-06-15 | 8-K | 8-K | 5.07 | 0000950170-22-011675 | 001-38787 | 221017789 | 34 | 215002 | 1 | 1 |
| 2022-06-10 | 8-K | 8-K | 7.01,9.01 | 0000950170-22-011430 | 001-38787 | 221007615 | 34 | 5826182 | 1 | 1 |
| 2022-06-03 | 8-K | 8-K | 3.01 | 0000950170-22-011148 | 001-38787 | 22994214 | 34 | 185935 | 1 | 1 |
| 2022-05-04 | 10-Q | 10-Q | 0000950170-22-007378 | 001-38787 | 22891537 | 34 | 5949100 | 1 | 1 | |
| 2022-05-04 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-007369 | 001-38787 | 22891408 | 34 | 258529 | 1 | 1 |
| 2022-04-26 | DEFA14A | DEFA14A | 0001140361-22-015850 | 001-38787 | 22851817 | 34 | 1606511 | |||
| 2022-04-26 | DEF 14A | DEF 14A | 0001140361-22-015849 | 001-38787 | 22851816 | 34 | 2030802 | |||
| 2022-02-24 | 10-K | 10-K | 0000950170-22-001958 | 001-38787 | 22670886 | 34 | 10100616 | 1 | 1 | |
| 2022-02-24 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-001956 | 001-38787 | 22670800 | 34 | 258405 | 1 | 1 |
| 2022-02-11 | SC 13G/A | slatepath-cycn123121a1.htm | 0001172661-22-000383 | 005-90979 | 22621896 | 34 | 56243 | |||
| 2022-02-11 | SC 13G/A | SC 13G/A | 0001193125-22-035595 | 005-90979 | 22616598 | 34 | 185809 | |||
| 2022-02-09 | SC 13G/A | SC 13G/A | 0001193125-22-032020 | 005-90979 | 22604522 | 34 | 91370 | |||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-000939 | 005-90979 | 22604256 | 34 | 8242 | |||
| 2022-01-24 | 4 | FORM 4 | 0001140361-22-002458 | 4983 | ||||||
| 2022-01-24 | 4 | FORM 4 | 0001140361-22-002456 | 4991 | ||||||
| 2022-01-24 | 4 | FORM 4 | 0001140361-22-002453 | 7218 | ||||||
| 2022-01-24 | 4 | FORM 4 | 0001140361-22-002451 | 4987 | ||||||
| 2021-12-10 | 4 | FORM 4 | 0001140361-21-041210 | 12632 | ||||||
| 2021-12-10 | 4 | FORM 4 | 0001140361-21-041209 | 11821 | ||||||
| 2021-12-10 | 4 | FORM 4 | 0001140361-21-041208 | 12426 | ||||||
| 2021-11-09 | 10-Q | 10-Q | 0000950170-21-003724 | 001-38787 | 211391936 | 34 | 7149277 | 1 | 1 | |
| 2021-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-003725 | 001-38787 | 211391926 | 34 | 259186 | 1 | 1 |
| 2021-10-28 | 8-K | 8-K | 5.02 | 0001140361-21-035774 | 001-38787 | 211359113 | 34 | 164459 | 1 | 1 |
| 2021-09-30 | 8-K | 8-K | 7.01,9.01 | 0001140361-21-033010 | 001-38787 | 211293814 | 34 | 11641693 | 1 | 1 |
| 2021-09-07 | UPLOAD | filename1.pdf | 0000000000-21-010836 | 39393 | ||||||
| 2021-08-27 | 10-Q/A | 10-Q/A | 0001140361-21-029588 | 001-38787 | 211219602 | 34 | 236544 | 1 | 1 | |
| 2021-08-27 | 10-Q/A | 10-Q/A | 0001140361-21-029585 | 001-38787 | 211219433 | 34 | 232016 | 1 | 1 | |
| 2021-08-27 | 10-K/A | 10-K/A | 0001140361-21-029579 | 001-38787 | 211219321 | 34 | 261500 | 1 | 1 | |
| 2021-08-27 | CORRESP | filename1.htm | 0001140361-21-029575 | 8981 | ||||||
| 2021-08-24 | UPLOAD | filename1.pdf | 0000000000-21-010341 | 43795 | ||||||
| 2021-08-19 | 8-K | 8-K | 5.02 | 0001140361-21-028904 | 001-38787 | 211190847 | 34 | 159624 | 1 | 1 |
| 2021-07-30 | S-8 | S-8 | 0001140361-21-026239 | 333-258316 | 211133006 | 33 | 88378 | |||
| 2021-07-29 | 10-Q | 10-Q | 0001564590-21-039205 | 001-38787 | 211128321 | 34 | 7911701 | 1 | 1 | |
| 2021-07-29 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-039201 | 001-38787 | 211128286 | 34 | 320074 | 1 | 1 |
| 2021-06-28 | 4 | FORM 4 | 0001140361-21-022583 | 12318 | ||||||
| 2021-06-28 | 4 | FORM 4 | 0001140361-21-022578 | 12286 | ||||||
| 2021-06-28 | 4 | FORM 4 | 0001140361-21-022575 | 11548 | ||||||
| 2021-06-28 | 4 | FORM 4 | 0001140361-21-022569 | 11619 | ||||||
| 2021-06-28 | 4 | FORM 4 | 0001140361-21-022553 | 12186 | ||||||
| 2021-06-28 | 4 | FORM 4 | 0001140361-21-022549 | 11619 | ||||||
| 2021-06-28 | 4 | FORM 4 | 0001140361-21-022547 | 4849 | ||||||
| 2021-06-28 | 4 | FORM 4 | 0001140361-21-022544 | 12214 | ||||||
| 2021-06-25 | 8-K | 8-K | 5.07 | 0001140361-21-022349 | 001-38787 | 211048334 | 34 | 31243 | ||
| 2021-06-24 | 424B4 | 424B4 | 0001140361-21-022140 | 333-257145 | 211041201 | 33 | 679388 | |||
| 2021-06-23 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-06-23 16:00:00 | 9999999995-21-002479 | 333-257145 | 211040484 | 33 | 1674 | ||
| 2021-06-23 | S-3/A | S-3/A | 0001140361-21-021998 | 333-257145 | 211037853 | 33 | 773448 | |||
| 2021-06-21 | CORRESP | filename1.htm | 0001140361-21-021690 | 8450 | ||||||
| 2021-06-21 | UPLOAD | filename1.pdf | 0000000000-21-007538 | 40163 | ||||||
| 2021-06-17 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-21-012331 | 021-403393 | 211025460 | 33 | 13387 | ||
| 2021-06-16 | S-3 | S-3 | 0001140361-21-021236 | 333-257145 | 211022058 | 33 | 1024848 | |||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0000899243-21-022327 | 11641 | ||||||
| 2021-06-07 | 4 | FORM 4 | 0001140361-21-020090 | 7132 | ||||||
| 2021-06-07 | SC 13D/A | SC 13DA | 0001140361-21-020086 | 005-90979 | 211000425 | 34 | 50410 | |||
| 2021-06-07 | 4 | xslF345X03/ownership.xml | 0000902664-21-003032 | 7585 | ||||||
| 2021-06-04 | 8-K | 8-K | 1.01,3.02,9.01 | 0001140361-21-019923 | 001-38787 | 21997011 | 34 | 56873 | ||
| 2021-05-19 | 3 | FORM 3 | 0001140361-21-018080 | 9899 | ||||||
| 2021-05-14 | SC 13D | SC 13D | 0001140361-21-017445 | 005-90979 | 21925632 | 34 | 73273 | |||
| 2021-05-10 | 4 | FORM 4 | 0001140361-21-016532 | 7390 | ||||||
| 2021-05-06 | 4 | FORM 4 | 0001140361-21-016304 | 14208 | ||||||
| 2021-05-04 | 8-K | 8-K | 1.02,9.01 | 0001140361-21-015739 | 001-38787 | 21889196 | 34 | 45556 | ||
| 2021-04-30 | 10-Q | 10-Q | 0001564590-21-022522 | 001-38787 | 21877758 | 34 | 5041161 | 1 | ||
| 2021-04-28 | DEFA14A | DEFA14A | 0001140361-21-014661 | 001-38787 | 21861285 | 34 | 1603359 | |||
| 2021-04-28 | DEF 14A | DEF 14A | 0001140361-21-014660 | 001-38787 | 21861280 | 34 | 1882261 | |||
| 2021-04-27 | 8-K | 8-K | 2.02,7.01,9.01 | 0001140361-21-014426 | 001-38787 | 21856202 | 34 | 10088531 | ||
| 2021-04-26 | 8-K | 8-K | 5.02,7.01,9.01 | 0001140361-21-014205 | 001-38787 | 21851868 | 34 | 37648 | ||
| 2021-03-19 | 8-K/A | 8-K/A | 8.01,9.01 | 0001140361-21-009236 | 001-38787 | 21756418 | 34 | 31169 | ||
| 2021-03-18 | 8-K | 8-K | 8.01,9.01 | 0001140361-21-009117 | 001-38787 | 21755078 | 34 | 30348 | ||
| 2021-03-01 | 4 | FORM 4 | 0001140361-21-006649 | 5021 | ||||||
| 2021-03-01 | 4 | FORM 4 | 0001140361-21-006641 | 5038 | ||||||
| 2021-02-25 | 10-K | 10-K | 0001564590-21-008434 | 001-38787 | 21676432 | 34 | 9104287 | 1 | ||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001193125-21-042136 | 005-90979 | 21631452 | 34 | 203573 | |||
| 2021-02-12 | SC 13G | SCHEDULE 13/G FILING BY CYCLERION ON BEHALF OF MFN PARTNERS | 0000904454-21-000194 | 005-90979 | 21629357 | 34 | 132214 | |||
| 2021-02-08 | SC 13G/A | filing.txt | 0000315066-21-000940 | 005-90979 | 21599454 | 34 | 8333 | |||
| 2021-02-05 | SC 13G/A | SC 13G/A | 0001193125-21-030235 | 005-90979 | 21594671 | 34 | 35011 | |||
| 2021-01-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-21-007746 | 001-38787 | 21525076 | 34 | 13756272 | ||
| 2021-01-11 | 3 | FORM 3 | 0001140361-21-000823 | 26594 | ||||||
| 2021-01-11 | 3 | FORM 3 | 0001140361-21-000821 | 35907 | ||||||
| 2020-12-30 | 3 | FORM 3 | 0001140361-20-029981 | 23143 | ||||||
| 2020-12-30 | 4 | FORM 4 | 0001140361-20-029869 | 4909 | ||||||
| 2020-12-21 | 8-K | 8-K | 5.02 | 0001193125-20-323185 | 001-38787 | 201404724 | 34 | 21101 | ||
| 2020-11-12 | 4 | FORM 4 SUBMISSION | 0001209191-20-058031 | 5215 | ||||||
| 2020-11-10 | 4 | FORM 4 SUBMISSION | 0001209191-20-057768 | 4890 | ||||||
| 2020-11-06 | 4 | FORM 4 SUBMISSION | 0001209191-20-057302 | 5316 | ||||||
| 2020-11-05 | 10-Q | 10-Q | 0001564590-20-050844 | 001-38787 | 201288595 | 34 | 5409687 | 1 | ||
| 2020-10-14 | 8-K | FORM 8-K | 8.01,9.01 | 0001104659-20-114699 | 001-38787 | 201238215 | 34 | 2545816 | ||
| 2020-10-01 | 8-K | FORM 8-K | 8.01 | 0001104659-20-110691 | 001-38787 | 201214394 | 34 | 18187 | ||
| 2020-09-22 | S-8 | FORM S-8 | 0001104659-20-107118 | 333-248957 | 201187625 | 33 | 67095 | |||
| 2020-09-09 | SC 13G/A | us23255m1053_090920.txt | 0000834237-20-010209 | 005-90979 | 201166524 | 34 | 12179 | |||
| 2020-09-03 | 424B5 | 424B5 | 0001104659-20-102276 | 333-240095 | 201159803 | 33 | 751905 | |||
| 2020-09-03 | 8-K | FORM 8-K | 1.01,9.01 | 0001104659-20-102011 | 001-38787 | 201158209 | 34 | 275414 | ||
| 2020-08-17 | 424B4 | 424B4 | 0001104659-20-095986 | 333-242334 | 201108918 | 33 | 1379643 | |||
| 2020-08-14 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-08-14 16:00:00 | 9999999995-20-002162 | 333-242334 | 201107821 | 33 | 1674 | ||
| 2020-08-12 | UPLOAD | filename1.pdf | 0000000000-20-007365 | 40099 | ||||||
| 2020-08-12 | CORRESP | filename1.htm | 0001104659-20-093961 | 9356 | ||||||
| 2020-08-11 | D | xslFormDX01/primary_doc.xml | 06b | 0001104659-20-093290 | 021-372991 | 201092442 | 33 | 13591 | ||
| 2020-08-10 | 3 | xslF345X02/ownership.xml | 0000902664-20-002945 | 13511 | ||||||
| 2020-08-10 | SC 13G | CYCLERION THERAPEUTICS, INC. | 0000902664-20-002944 | 005-90979 | 201089576 | 34 | 76612 | |||
| 2020-08-07 | S-3 | FORM S-3 | 0001104659-20-091997 | 333-242334 | 201085344 | 33 | 1514074 | |||
| 2020-08-03 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-20-089685 | 001-38787 | 201069847 | 34 | 94177 | ||
| 2020-08-03 | 10-Q | FORM 10-Q | 0001104659-20-089193 | 001-38787 | 201067074 | 34 | 4372727 | 1 | ||
| 2020-07-31 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-07-31 16:00:00 | 9999999995-20-001998 | 333-240095 | 201067702 | 33 | 1674 | ||
| 2020-07-30 | CORRESP | filename1.htm | 0001104659-20-088538 | 7254 | ||||||
| 2020-07-30 | S-3/A | FORM S-3/A | 0001104659-20-088412 | 333-240095 | 201061908 | 33 | 724817 | |||
| 2020-07-30 | UPLOAD | filename1.pdf | 0000000000-20-006988 | 40190 | ||||||
| 2020-07-24 | S-3 | S-3 | 0001104659-20-086517 | 333-240095 | 201047574 | 33 | 1122559 | |||
| 2020-07-09 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001104659-20-082390 | 001-38787 | 201020913 | 34 | 16504457 | ||
| 2020-06-18 | 8-K | FORM 8-K | 5.07,7.01,9.01 | 0001104659-20-074702 | 001-38787 | 20973318 | 34 | 66505 | ||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037589 | 5225 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037587 | 5247 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037580 | 5261 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037575 | 5248 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037573 | 5262 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037571 | 5329 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037568 | 5266 | ||||||
| 2020-06-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-037566 | 5265 | ||||||
| 2020-05-04 | 10-Q | 10-Q | 0001104659-20-056280 | 001-38787 | 20845772 | 34 | 3719977 | 1 | ||
| 2020-04-23 | DEFA14A | DEFA14A | 0001140361-20-009597 | 001-38787 | 20811700 | 34 | 2127590 | |||
| 2020-04-23 | DEF 14A | DEF 14A | 0001140361-20-009594 | 001-38787 | 20811651 | 34 | 2054181 | |||
| 2020-04-14 | 8-K | FORM 8-K | 2.02,7.01,8.01,9.01 | 0001104659-20-046446 | 001-38787 | 20791975 | 34 | 9561613 | ||
| 2020-04-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-022657 | 9547 | ||||||
| 2020-03-12 | 10-K | FORM 10-K | 0001104659-20-032554 | 001-38787 | 20709568 | 34 | 6800408 | 1 | ||
| 2020-03-05 | 8-K | FORM 8-K | 1.01,9.01 | 0001104659-20-029761 | 001-38787 | 20691557 | 34 | 78816 | ||
| 2020-02-25 | 4 | FORM 4 SUBMISSION | 0001209191-20-012430 | 5398 | ||||||
| 2020-02-14 | SC 13G | SC 13G | 0001193125-20-038302 | 005-90979 | 20620312 | 34 | 35024 | |||
| 2020-02-14 | SC 13G/A | PRIMARY DOCUMENT | 0001654954-20-001573 | 005-90979 | 20614632 | 34 | 69291 | |||
| 2020-02-13 | SC 13G/A | SCH 13G/A FILING BY MFN PARTNERS FOR ISSUER CYCLERION THERAPEUTICS, TO BE FILED | 0000904454-20-000173 | 005-90979 | 20611881 | 34 | 114736 | |||
| 2020-02-07 | SC 13G | filing.txt | 0000315066-20-000899 | 005-90979 | 20585552 | 34 | 8281 | |||
| 2020-02-07 | SC 13G | us23255m1053_020620.txt | 0000834237-20-008046 | 005-90979 | 20584694 | 34 | 13263 | |||
| 2020-02-03 | SC 13G | SC 13G | 0001193125-20-023050 | 005-90979 | 20569434 | 34 | 208646 | |||
| 2020-01-13 | 8-K | FORM 8-K | 7.01,9.01 | 0001104659-20-003162 | 001-38787 | 20522629 | 34 | 4335916 | ||
| 2019-12-31 | 4 | FORM 4 SUBMISSION | 0001209191-19-062322 | 7350 | ||||||
| 2019-12-27 | SC 13G | cycn13g.htm | 0000935836-19-000672 | 005-90979 | 191314076 | 34 | 49646 | |||
| 2019-11-26 | 4 | FORM 4 SUBMISSION | 0001209191-19-058165 | 6132 | ||||||
| 2019-11-26 | 4 | FORM 4 SUBMISSION | 0001209191-19-058163 | 6118 | ||||||
| 2019-11-26 | 4 | FORM 4 SUBMISSION | 0001209191-19-058162 | 6134 | ||||||
| 2019-11-26 | 4 | FORM 4 SUBMISSION | 0001209191-19-058158 | 6133 | ||||||
| 2019-11-19 | 4 | FORM 4 SUBMISSION | 0001209191-19-057112 | 4964 | ||||||
| 2019-11-12 | 4 | FORM 4 SUBMISSION | 0001209191-19-056008 | 5402 | ||||||
| 2019-11-12 | 10-Q | 10-Q | 0001104659-19-062590 | 001-38787 | 191209192 | 34 | 5037483 | 1 | ||
| 2019-10-30 | 8-K | 8-K | 2.02,2.05,8.01,9.01 | 0001104659-19-057505 | 001-38787 | 191177856 | 34 | 2252870 | ||
| 2019-09-25 | 8-K | 8-K | 5.02,9.01 | 0001104659-19-051352 | 001-38787 | 191114543 | 34 | 139764 | ||
| 2019-09-20 | 4/A | FORM 4/A SUBMISSION | 0001209191-19-050311 | 24178 | ||||||
| 2019-09-20 | 4/A | FORM 4/A SUBMISSION | 0001209191-19-050309 | 22766 | ||||||
| 2019-09-20 | 4/A | FORM 4/A SUBMISSION | 0001209191-19-050308 | 13041 | ||||||
| 2019-08-12 | 10-Q | 10-Q | 0001104659-19-045323 | 001-38787 | 191017283 | 34 | 4845193 | 1 | ||
| 2019-08-12 | 8-K | 8-K | 2.02,9.01 | 0001104659-19-045189 | 001-38787 | 191014414 | 34 | 149762 | ||
| 2019-07-12 | 4 | FORM 4 SUBMISSION | 0001209191-19-041920 | 9876 | ||||||
| 2019-06-17 | SC 13G | PRIMARY DOCUMENT | 0001654954-19-007382 | 005-90979 | 19900757 | 34 | 69485 | |||
| 2019-06-04 | 4 | FORM 4 SUBMISSION | 0001209191-19-034383 | 5264 | ||||||
| 2019-06-04 | 4 | FORM 4 SUBMISSION | 0001209191-19-034382 | 5265 | ||||||
| 2019-06-04 | 4 | FORM 4 SUBMISSION | 0001209191-19-034379 | 5328 | ||||||
| 2019-06-04 | 4 | FORM 4 SUBMISSION | 0001209191-19-034376 | 5261 | ||||||
| 2019-06-04 | 4 | FORM 4 SUBMISSION | 0001209191-19-034375 | 5247 | ||||||
| 2019-06-04 | 4 | FORM 4 SUBMISSION | 0001209191-19-034373 | 5260 | ||||||
| 2019-06-04 | 4 | FORM 4 SUBMISSION | 0001209191-19-034371 | 5246 | ||||||
| 2019-06-04 | 4 | FORM 4 SUBMISSION | 0001209191-19-034369 | 5224 | ||||||
| 2019-05-13 | 10-Q | 10-Q | 0001104659-19-028981 | 001-38787 | 19819283 | 34 | 2427727 | 1 | ||
| 2019-05-13 | 8-K | 8-K | 2.02,9.01 | 0001104659-19-028766 | 001-38787 | 19816877 | 34 | 116084 | ||
| 2019-05-01 | 4 | FORM 4 SUBMISSION | 0001209191-19-026820 | 5493 | ||||||
| 2019-05-01 | 3 | FORM 3 SUBMISSION | 0001209191-19-026819 | 6271 | ||||||
| 2019-04-23 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2019-04-23 16:00:00 | 9999999995-19-000803 | 333-230944 | 19762516 | 33 | 1673 | ||
| 2019-04-23 | 424B3 | 424B3 | 0001047469-19-002505 | 333-230944 | 19762149 | 33 | 4042814 | |||
| 2019-04-22 | CORRESP | filename1.htm | 0001104659-19-022786 | 12050 | ||||||
| 2019-04-18 | S-1 | S-1 | 0001047469-19-002389 | 333-230944 | 19756556 | 33 | 4130627 | |||
| 2019-04-17 | D | xslFormDX01/primary_doc.xml | 06b | 0001104659-19-021921 | 021-337559 | 19752810 | 33 | 16108 | ||
| 2019-04-16 | UPLOAD | filename1.pdf | 0000000000-19-007200 | 40004 | ||||||
| 2019-04-11 | SC 13G | 13G FILING FOR MFN AND CYCLERION - CREATED AND UPDATED ON 4.9.19 | 0000904454-19-000355 | 005-90979 | 19743522 | 34 | 155677 | |||
| 2019-04-10 | 4 | FORM 4 SUBMISSION | 0001209191-19-024237 | 11581 | ||||||
| 2019-04-10 | 4 | FORM 4 SUBMISSION | 0001209191-19-024236 | 9037 | ||||||
| 2019-04-09 | DRS | filename1.htm | 0000912057-19-000160 | 377-02587 | 19739956 | 33 | 4148884 | |||
| 2019-04-09 | 8-K | 8-K | 8.01,9.01 | 0001104659-19-020379 | 001-38787 | 19738508 | 34 | 45891 | ||
| 2019-04-04 | 4/A | FORM 4/A SUBMISSION | 0001209191-19-023727 | 5190 | ||||||
| 2019-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-19-023566 | 10997 | ||||||
| 2019-04-03 | 4/A | FORM 4/A SUBMISSION | 0001209191-19-023565 | 10112 | ||||||
| 2019-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-19-023556 | 36354 | ||||||
| 2019-04-03 | 3 | FORM 3 SUBMISSION | 0001209191-19-023554 | 6211 | ||||||
| 2019-04-03 | 3 | FORM 3 SUBMISSION | 0001209191-19-023522 | 6235 | ||||||
| 2019-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-19-023521 | 32181 | ||||||
| 2019-04-03 | 3 | FORM 3 SUBMISSION | 0001209191-19-023519 | 6189 | ||||||
| 2019-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-19-023517 | 15876 | ||||||
| 2019-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-19-023514 | 6658 | ||||||
| 2019-04-03 | 3 | FORM 3 SUBMISSION | 0001209191-19-023509 | 6154 | ||||||
| 2019-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-19-023507 | 6657 | ||||||
| 2019-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-19-023494 | 4722 | ||||||
| 2019-04-03 | 3 | FORM 3 SUBMISSION | 0001209191-19-023489 | 6182 | ||||||
| 2019-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-19-023488 | 4718 | ||||||
| 2019-04-03 | 3 | FORM 3 SUBMISSION | 0001209191-19-023487 | 6163 | ||||||
| 2019-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-19-023486 | 4704 | ||||||
| 2019-04-03 | 3 | FORM 3 SUBMISSION | 0001209191-19-023485 | 6162 | ||||||
| 2019-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-19-023461 | 4732 | ||||||
| 2019-04-03 | 3 | FORM 3 SUBMISSION | 0001209191-19-023460 | 6113 | ||||||
| 2019-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-19-023381 | 8004 | ||||||
| 2019-04-03 | 3 | FORM 3 SUBMISSION | 0001209191-19-023363 | 6138 | ||||||
| 2019-04-02 | 4 | 4 | 0001104659-19-019466 | 6843 | ||||||
| 2019-04-02 | 8-K | 8-K | 1.01,2.01,3.02,3.03,5.01,5.02,5.03,7.01,9.01 | 0001104659-19-019416 | 001-38787 | 19726059 | 34 | 5404782 | ||
| 2019-03-29 | S-8 | S-8 | 0001104659-19-018720 | 333-230615 | 19716993 | 33 | 690286 | |||
| 2019-03-19 | 8-K | 8-K | 5.02 | 0001104659-19-016052 | 001-38787 | 19692650 | 34 | 24493 | ||
| 2019-03-15 | 3 | 3 | 0001104659-19-014989 | 2780 | ||||||
| 2019-03-14 | 3 | 3 | 0001104659-19-014914 | 2840 | ||||||
| 2019-03-14 | 3 | 3 | 0001104659-19-014913 | 2830 | ||||||
| 2019-03-14 | 3 | 3 | 0001104659-19-014911 | 3727 | ||||||
| 2019-03-14 | SEC STAFF ACTION | filename1.pdf | 9999999997-19-001156 | 9879 | ||||||
| 2019-03-14 | UPLOAD | filename1.pdf | 0000000000-19-004815 | 45486 | ||||||
| 2019-03-14 | CERT | Form10_Cert_CYCN.pdf | 0001354457-19-000129 | 001-38787 | 19680175 | 34 | 80402 | |||
| 2019-03-12 | CORRESP | filename1.htm | 0001104659-19-014230 | 10490 | ||||||
| 2019-03-11 | 10-12B/A | 10-12B/A | 0001047469-19-001059 | 001-38787 | 19671059 | 34 | 4170936 | |||
| 2019-03-04 | 10-12B/A | 10-12B/A | 0001047469-19-000876 | 001-38787 | 19654550 | 34 | 5255789 | |||
| 2019-01-28 | 10-12B | 10-12B | 0001047469-19-000256 | 001-38787 | 19543863 | 34 | 7481642 | |||
| 2019-01-07 | DRSLTR | filename1.htm | 0001410578-19-000010 | 29893 | ||||||
| 2019-01-07 | DRS/A | filename1.htm | 0000912057-19-000008 | 377-02304 | 19513149 | 33 | 7328563 | |||
| 2018-12-18 | UPLOAD | filename1.pdf | 0000000000-18-038336 | 51727 | ||||||
| 2018-12-06 | DRSLTR | filename1.htm | 0001410578-18-000589 | 48550 | ||||||
| 2018-12-06 | DRS/A | filename1.htm | 0000912057-18-000507 | 377-02304 | 181220070 | 33 | 4077219 | |||
| 2018-11-06 | UPLOAD | filename1.pdf | 0000000000-18-034596 | 57713 | ||||||
| 2018-10-09 | DRSLTR | filename1.htm | 0001410578-18-000440 | 11480 |
One latest value per concept from companyfacts (262 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 45.54M | 2026-11-02 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| dei | EntityNumberOfEmployees | Entity Number of Employees | Employee | 0 | 2019-11-15 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-127116 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 5.70M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-30 | 0001193125-26-132193 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 21,664.12 | 2026-11-09 | S-8 | 2026-11-09 | 0001193125-26-453743 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 21,664.12 | 2026-11-09 | S-8 | 2026-11-09 | 0001193125-26-453743 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 249.01M | 2026-11-09 | S-8 | 2026-11-09 | 0001193125-26-453743 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-09 | S-8 | 2026-11-09 | 0001193125-26-453743 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 1.4 | 2026-07-09 | S-4/A | 2026-07-10 | 0001193125-26-299933 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | AccountsPayableRelatedPartiesCurrent | Accounts Payable, Related Parties, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0000950170-22-001958 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 | |
| us-gaap | AccountsReceivableRelatedPartiesCurrent | Accounts Receivable, Related Parties, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0000950170-22-001958 | |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025935 | |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025935 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 18,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-127116 | |
| us-gaap | AccruedVacationCurrent | Accrued Vacation, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025935 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 126,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277749 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 0 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 504.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 281.04M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.57M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 17.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits | Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units | USD | 705.44M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 7.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | AreaOfLand | Area of Land | sqft | 114,000 | 2019-04-01 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001104659-19-062590 | |
| us-gaap | AssetAcquisitionConsiderationTransferred | AssetAcquisitionConsiderationTransferred | USD | 8.00M | 2023-07-28 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 | |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | Assets | Assets | USD | 462.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 460.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 453.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents | USD | 81,000 | 2026-09-08 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net | USD | -3.28M | 2026-09-08 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0000950170-21-003724 |
| us-gaap | Cash | Cash | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008434 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 456.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 93.86M | 2019-12-31 | 2020 | Q1 | 10-Q | 2020-05-04 | 0001104659-20-056280 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 456.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 0 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-13 | 0001104659-19-028981 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 302.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 41.10M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007378 | |
| us-gaap | CommitmentsAndContingencies | Commitments and Contingencies | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 17.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 400.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 45.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 45.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -77,295 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -3.53M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense | Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense | USD | 100,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008434 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025935 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 100,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0000950170-23-021448 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 20,000 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 83.39M | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 57.62M | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 1,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0000950170-22-001958 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 10.38M | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 6.50M | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseOther | Deferred Tax Assets, Tax Deferred Expense, Other | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009223 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 0 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 83.39M | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 556,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001104659-20-032554 | |
| us-gaap | DefinedBenefitPlanBenefitObligation | Defined Benefit Plan, Benefit Obligation | USD | 0 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | DefinedBenefitPlanContributionsByEmployer | Defined Benefit Plan, Plan Assets, Contributions by Employer | USD | 200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 100,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.75 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | Depreciation | Depreciation | USD | 33,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025935 |
| us-gaap | DerivativeLiabilityFairValueOfCollateral | Derivative Liability, Fair Value of Collateral | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax | Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax | Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | USD | 15.75M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0000950170-23-063023 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -13.42 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.3 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007378 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -13.42 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.048 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.162 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 2.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions | Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | USD | 200,000 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-07-29 | 0001564590-21-039205 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 100,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0000950170-23-021448 | |
| us-gaap | EquitySecuritiesFvNiCurrentAndNoncurrent | EquitySecuritiesFvNiCurrentAndNoncurrent | USD | 5.00M | 2023-03-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 | |
| us-gaap | FutureMinimumSubleaseRentalsSaleLeasebackTransactions | Future Minimum Sublease Rentals, Sale Leaseback Transactions | USD | 500,000 | 2019-10-18 | 2019 | FY | 10-K | 2020-03-12 | 0001104659-20-032554 | |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009223 |
| us-gaap | GainLossOnTerminationOfLease | Gain (Loss) on Termination of Lease | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009223 |
| us-gaap | GainOnBusinessInterruptionInsuranceRecovery | Gain on Business Interruption Insurance Recovery | USD | 1.32M | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009223 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 12,355 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | ImpairmentOfInvestments | Other than Temporary Impairment Losses, Investments | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-127116 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -3.53M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -3.53M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -3.06M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -1.21 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -1.21 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTax | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | USD/shares | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | USD/shares | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 0 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 170,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | IncomeTaxReconciliationDispositionOfBusiness | Effective Income Tax Rate Reconciliation, Disposition of Business, Amount | USD | 9.80M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008434 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -741,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 571,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 22,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -155,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 2.89M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-13 | 0001104659-19-028981 |
| us-gaap | IncreaseDecreaseInAccountsPayableRelatedParties | Increase (Decrease) in Accounts Payable, Related Parties | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009223 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 1.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -1.00M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 |
| us-gaap | IncreaseDecreaseInAccountsReceivableRelatedParties | Increase (Decrease) in Accounts Receivable, Related Parties | USD | 0 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-07-28 | 0000950170-23-035558 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | 12.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | -5.27M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-13 | 0001104659-19-028981 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 52,000 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-13 | 0001104659-19-028981 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 52,000 | 2019-01-01 | 2019-03-31 | 2020 | Q1 | 10-Q | 2020-05-04 | 0001104659-20-056280 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | -272,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | 3.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | InvestmentIncomeNonoperating | Investment Income, Nonoperating | USD | 588,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008434 |
| us-gaap | LeaseCost | Lease, Cost | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0000950170-22-021966 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 6.30M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-07-29 | 0001564590-21-039205 | |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.109 | 2019-04-01 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001104659-19-062590 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 1.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 24.05M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008434 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 382,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 6.44M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008434 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 410,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 401,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 392,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 314,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceived | Lessor, Operating Lease, Payments to be Received | USD | 16.33M | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-03 | 0001104659-20-089193 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedFiveYears | Lessor, Operating Lease, Payment to be Received, Year Five | USD | 1.78M | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-03 | 0001104659-20-089193 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedFourYears | Lessor, Operating Lease, Payment to be Received, Year Four | USD | 1.73M | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-03 | 0001104659-20-089193 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths | Lessor, Operating Lease, Payment to be Received, Year One | USD | 1.01M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001104659-20-032554 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear | Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year | USD | 800,000 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-03 | 0001104659-20-089193 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedThereafter | Lessor, Operating Lease, Payment to be Received, after Year Five | USD | 8.69M | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-03 | 0001104659-20-089193 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedThreeYears | Lessor, Operating Lease, Payment to be Received, Year Three | USD | 1.68M | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-03 | 0001104659-20-089193 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedTwoYears | Lessor, Operating Lease, Payment to be Received, Year Two | USD | 1.64M | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-03 | 0001104659-20-089193 | |
| us-gaap | LettersOfCreditOutstandingAmount | Letters of Credit Outstanding, Amount | USD | 100,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | Liabilities | Liabilities | USD | 45.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 462.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 44.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | LossContingencyAccrualAtCarryingValue | Loss Contingency Accrual | USD | 0 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 351.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -297,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -49.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -77.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1 | Noncash or Part Noncash Acquisition, Other Liabilities Assumed | USD | 3.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | NoninterestExpenseDirectorsFees | Noninterest Expense Directors Fees | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 4,190 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0000950170-22-001958 | |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 81,485 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -81,485 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-127116 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 3.30M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 1.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 287,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 984,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.89M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009223 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 967,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | OperatingLeasesRentExpenseSubleaseRentals1 | Operating Leases, Rent Expense, Sublease Rentals | USD | 200,000 | 2019-04-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-12 | 0001104659-19-045323 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.061 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0000950170-22-001958 | |
| us-gaap | OtherAccruedLiabilitiesNoncurrent | Other Accrued Liabilities, Noncurrent | USD | 376,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 11,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-05 | 0000950170-24-025935 | |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | 2,000 | 2020-01-01 | 2020-03-31 | 2021 | Q1 | 10-Q | 2021-04-30 | 0001564590-21-022522 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 5.56M | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-13 | 0001104659-19-028981 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 52,000 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-13 | 0001104659-19-028981 | |
| us-gaap | OtherLongTermInvestments | Other Long-term Investments | USD | 5.35M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 | |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 4,190 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | OtherSundryLiabilitiesCurrent | Other Sundry Liabilities, Current | USD | 3.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 1.37M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 10.38M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008434 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 297,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | PaymentsToEmployees | Payments to Employees | USD | 10.00M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0000950170-22-021966 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 100.00M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0000950170-23-063023 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0000950170-23-063023 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 4.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 112,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 | |
| us-gaap | ProceedsFromContributedCapital | Proceeds from Contributed Capital | USD | 46.44M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008434 |
| us-gaap | ProceedsFromDivestitureOfBusinesses | Proceeds from Divestiture of Businesses | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 3.05M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009223 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0000950170-22-001958 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009223 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -77.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 126,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277749 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 367,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 69,130 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 101,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007378 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 2.70M | 2019-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008434 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0000950170-22-001958 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | -565,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | RestructuringReserveAccrualAdjustment1 | Restructuring Reserve, Accrual Adjustment | USD | 0 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 0 | 2023-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -113.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 2.30M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008434 |
| us-gaap | RevenueFromRelatedParties | Revenue from Related Parties | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0000950170-22-001958 |
| us-gaap | RevenueRecognitionMilestoneMethodRevenueRecognized | Revenue Recognition, Milestone Method, Revenue Recognized | USD | 200,000 | 2025-01-01 | 2025-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 |
| us-gaap | Revenues | Revenues | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 1.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | SecurityDepositLiability | Security Deposit Liability | USD | 3.80M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0000950170-22-001958 | |
| us-gaap | SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount | Settlement of Asset Retirement Obligations Through Noncash Payments, Amount | USD | 8.00M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 100,000 | 2024-08-01 | 2024-08-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 17.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 809,417 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-12 | 0000950170-23-021448 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.411 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.038 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | ||
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 315,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001104659-19-062590 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 2.48M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001104659-19-062590 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 14.84 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001104659-19-062590 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054602 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 150,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0000950170-21-003724 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054602 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054602 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.97 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0000950170-22-001958 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 1.08M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001104659-19-062590 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 7,500 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054602 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 40.2 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054602 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 7.20M | 2019-04-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001104659-19-062590 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054602 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationNumberOfEmployeesAffected | Share-based Payment Arrangement, Plan Modification, Number of Grantees Affected | employee | 143 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-07-29 | 0001564590-21-039205 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 8.18 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001104659-19-062590 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 2.01 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0000950170-21-003724 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 13.21 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001104659-19-062590 |
| us-gaap | ShortTermBorrowings | Short-term Debt | USD | 3.50M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-22 | 0000950170-23-009223 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 391.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 5.09M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001193125-26-332842 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 24,250 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-25 | 0001564590-21-008434 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 47,121 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001104659-19-062590 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 150.57M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 151.00M | 2025-09-15 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 | |
| us-gaap | SubleaseIncome | Sublease Income | USD | 300,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0000950170-22-001958 |
| us-gaap | TaxCreditCarryforwardAmount | Tax Credit Carryforward, Amount | USD | 10.80M | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | TenantImprovements | Tenant Improvements | USD | 2.30M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001104659-19-062590 | |
| us-gaap | TransferToInvestments | Transfer to Investments | USD | 5.35M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K/A | 2025-11-12 | 0001193125-25-277621 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | S-4/A | 2026-07-22 | 0001193125-26-312558 | |||
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 26.50M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001104659-20-032554 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 5.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 43.42M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-04 | 0000950170-22-007378 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 5.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-448636 |